THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 113 filers reported holding THERAVANCE BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $3,725,040 | +11.4% | 332,000 | +0.6% | 0.06% | +28.9% |
| Q3 2022 | $3,345,000 | +218.0% | 330,000 | +199.7% | 0.04% | +246.2% |
| Q1 2022 | $1,052,000 | +142.4% | 110,100 | +267.0% | 0.01% | +116.7% |
| Q2 2021 | $434,000 | -64.5% | 30,000 | -50.0% | 0.01% | -76.9% |
| Q1 2021 | $1,222,000 | +28.5% | 60,000 | -6.8% | 0.03% | +18.2% |
| Q3 2020 | $951,000 | +65.1% | 64,400 | +134.9% | 0.02% | +15.8% |
| Q2 2020 | $576,000 | -0.3% | 27,417 | +9.7% | 0.02% | -40.6% |
| Q1 2020 | $578,000 | -80.3% | 25,000 | -86.1% | 0.03% | -78.4% |
| Q2 2019 | $2,939,000 | +107.4% | 180,000 | +188.0% | 0.15% | +89.7% |
| Q1 2019 | $1,417,000 | – | 62,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madison Avenue Partners, LP | 7,012,226 | $60,515,510 | 8.59% |
| Irenic Capital Management LP | 2,760,948 | $23,826,981 | 6.76% |
| Newtyn Management, LLC | 1,841,560 | $15,892,663 | 3.92% |
| Weiss Asset Management LP | 7,457,060 | $64,354,428 | 3.81% |
| Park West Asset Management LLC | 1,983,251 | $17,115,456 | 1.57% |
| Baupost Group | 7,419,226 | $64,028 | 1.23% |
| Oasis Management Co Ltd. | 953,254 | $8,226,582 | 0.36% |
| Chescapmanager LLC | 287,333 | $2,479,684 | 0.32% |
| GSA CAPITAL PARTNERS LLP | 325,985 | $2,813 | 0.24% |
| Virtus ETF Advisers LLC | 29,232 | $252,272 | 0.15% |